RESUMO
The use of dietary supplements (DS) is pervasive and can provide substantial amounts of micronutrients to those who use them. Therefore when characterizing dietary intakes, describing the prevalence of inadequacy or excess, or assessing relations between nutrients and health outcomes, it is critical to incorporate DS intakes to improve exposure estimates. Unfortunately, little is known about the best methods to assess DS, and the structure of measurement error in DS reporting. Several characteristics of nutrients from DS are salient to understand when comparing to those in foods. First, DS can be consumed daily or episodically, in bolus form and can deliver discrete and often very high doses of nutrients that are not limited by energy intakes. These characteristics contribute to bimodal distributions and distributions severely skewed to the right. Labels on DS often provide nutrient forms that differ from those found in conventional foods, and underestimate analytically derived values. Finally, the bioavailability of many nutrient-containing DS is not known and it may not be the same as the nutrients in a food matrix. Current methods to estimate usual intakes are not designed specifically to handle DS. Two temporal procedures are described to refer to the order that nutrient intakes are combined relative to usual intake procedures, referred to as a "shrinking" the distribution to remove random error. The "shrink then add" approach is preferable to the "add then shrink" approach when users and nonusers are combined for most research questions. Stratifying by DS before usual intake methods is another defensible option. This review describes how to incorporate nutrient intakes from DS to usual intakes from foods, and describes the available methods and fit-for-purpose of different analytical strategies to address research questions where total usual intakes are of interest at the group level for use in nutrition research and to inform policy decisions. Clinical Trial Registry: NCT03400436.
Assuntos
Suplementos Nutricionais , Vigilância da População , Guias de Prática Clínica como Assunto , Projetos de Pesquisa , Humanos , Necessidades NutricionaisRESUMO
BACKGROUND: Since its emergence in 2013, porcine epidemic diarrhea virus (PEDV) spread rapidly throughout the country due, in part, to contaminated livestock trailers. The objective of this study was to test the efficacy of an accelerated hydrogen peroxide (AHP) disinfectant for inactivating PEDV in swine feces on metal surfaces under freezing conditions. One 15.24 X 15.24 X 2.54 cm aluminum coupon, contaminated with swine feces, and randomly matched to one pig was the experimental unit. Eight treatment groups representing two AHP concentrations (1:16 and 1:32) in a 10% propylene glycol solution, two contact times in a -10 °C freezer (40 min and 60 min), and two levels of fecal contamination (5 mL and 10 mL) in addition to negative and positive control groups were evaluated. Forty 3-week-old pigs, intragastrically inoculated with the contents of the coupons after treatment, were used as a bioassay to determine the infectivity of PEDV after treatment. Infectivity was determined by detection of virus with a nucleocapsid (N) gene-based quantitative real-time reverse transcription polymerase chain reaction (RT-qPCR) on rectal swabs collected from the inoculated pigs on days three and seven post-inoculation. RESULTS: All post-treatment swabs from the negative control coupons were negative for PEDV via RT-qPCR. All post-treatment swabs collected from coupons in the AHP disinfectant treatment groups and the positive control group were positive for PEDV via RT-qPCR. For the bioassay, no rectal swabs from pigs in the negative control (0 of 4) or the AHP disinfectant treatment groups (0 of 32) were positive for PEDV. Rectal swabs from all pigs within the positive control group (4 of 4) were positive for PEDV by RT-qPCR. CONCLUSIONS: Under the conditions of this study, 1:16 and 1:32 dilutions of the AHP disinfectant successfully inactivated PEDV in swine feces on metal surfaces when applied at -10 °C with 40 or 60 min of contact time. This study also suggests that a positive RT-qPCR result for PEDV on an environmental sample should be expected when the AHP disinfectant is applied under freezing conditions, but does not necessarily indicate that an infectious dose of PEDV remains after disinfection.
Assuntos
Infecções por Coronavirus/veterinária , Desinfetantes/farmacologia , Fezes/virologia , Peróxido de Hidrogênio/farmacologia , Vírus da Diarreia Epidêmica Suína/efeitos dos fármacos , Doenças dos Suínos/prevenção & controle , Alumínio/química , Animais , Bioensaio/veterinária , Temperatura Baixa , Infecções por Coronavirus/prevenção & controle , Infecções por Coronavirus/virologia , Desinfetantes/química , Peróxido de Hidrogênio/química , Reto/virologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Suínos , Doenças dos Suínos/virologiaRESUMO
BACKGROUND: Multivitamin-mineral (MVM) products are the most commonly used supplements in the United States, followed by multivitamin (MV) products. Two randomized clinical trials (RCTs) did not show an effect of MVMs or MVs on cardiovascular disease (CVD) mortality; however, no clinical trial data are available for women with MVM supplement use and CVD mortality. OBJECTIVE: The objective of this research was to examine the association between MVM and MV use and CVD-specific mortality among US adults without CVD. METHODS: A nationally representative sample of adults from the restricted data NHANES III (1988-1994; n = 8678; age ≥40 y) were matched with mortality data reported by the National Death Index through 2011 to examine associations between MVM and MV use and CVD mortality by using Cox proportional hazards models, adjusting for multiple potential confounders. RESULTS: We observed no significant association between CVD mortality and users of MVMs or MVs compared with nonusers; however, when users were classified by the reported length of time products were used, a significant association was found with MVM use of >3 y compared with nonusers (HR: 0.65; 95% CI: 0.49, 0.85). This finding was largely driven by the significant association among women (HR: 0.56; 95% CI: 0.37, 0.85) but not men (HR: 0.79; 95% CI: 0.44, 1.42). No significant association was observed for MV products and CVD mortality in fully adjusted models. CONCLUSIONS: In this nationally representative data set with detailed information on supplement use and CVD mortality data â¼20 y later, we found an association between MVM use of >3 y and reduced CVD mortality risk for women when models controlled for age, race, education, body mass index, alcohol, aspirin use, serum lipids, blood pressure, and blood glucose/glycated hemoglobin. Our results are consistent with the 1 available RCT in men, indicating no relation with MVM use and CVD mortality.
Assuntos
Doenças Cardiovasculares/mortalidade , Doenças Cardiovasculares/prevenção & controle , Suplementos Nutricionais , Comportamento de Redução do Risco , Oligoelementos/administração & dosagem , Vitaminas/administração & dosagem , Glicemia , Pressão Sanguínea , Índice de Massa Corporal , Estudos Transversais , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Inquéritos Nutricionais , Modelos de Riscos Proporcionais , Fatores de Risco , Estados Unidos/epidemiologiaRESUMO
BACKGROUND: Dietary supplements are used by one-third of children. We examined motivations for supplement use in children, the types of products used by motivations, and the role of physicians and health care practitioners in guiding choices about supplements. METHODS: We examined motivations for dietary supplement use reported for children (from birth to 19 y of age; n = 8,245) using the National Health and Nutrition Examination Survey 2007-2010. RESULTS: Dietary supplements were used by 31% of children; many different reasons were given as follows: to "improve overall health" (41%), to "maintain health" (37%), for "supplementing the diet" (23%), to "prevent health problems" (20%), and to "boost immunity" (14%). Most children (~90%) who use dietary supplements use a multivitamin-mineral or multivitamin product. Supplement users tend to be non-Hispanic white, have higher family incomes, report more physical activity, and have health insurance. Only a small group of supplements used by children (15%) were based on the recommendation of a physician or other health care provider. CONCLUSION: Most supplements used by children are not under the recommendation of a health care provider. The most common reasons for use of supplements in children are for health promotion, yet little scientific data support this notion in nutrient-replete children.
Assuntos
Suplementos Nutricionais , Adolescente , Adulto , Criança , Pré-Escolar , Estudos Transversais , Feminino , Humanos , Lactente , Masculino , Inquéritos Nutricionais , Estados Unidos , Adulto JovemRESUMO
Dietary supplement use has steadily increased over time since the 1970s; however, no current data exist for the U.S. population. Therefore, the purpose of this analysis was to estimate dietary supplement use using the NHANES 2003-2006, a nationally representative, cross-sectional survey. Dietary supplement use was analyzed for the U.S. population (≥1 y of age) by the DRI age groupings. Supplement use was measured through a questionnaire and was reported by 49% of the U.S. population (44% of males, 53% of females). Multivitamin-multimineral use was the most frequently reported dietary supplement (33%). The majority of people reported taking only 1 dietary supplement and did so on a daily basis. Dietary supplement use was lowest in obese adults and highest among non-Hispanic whites, older adults, and those with more than a high-school education. Between 28 and 30% reported using dietary supplements containing vitamins B-6, B-12, C, A, and E; 18-19% reported using iron, selenium, and chromium; and 26-27% reported using zinc- and magnesium-containing supplements. Botanical supplement use was more common in older than in younger age groups and was lowest in those aged 1-13 y but was reported by ~20% of adults. About one-half of the U.S. population and 70% of adults ≥ 71 y use dietary supplements; one-third use multivitamin-multimineral dietary supplements. Given the widespread use of supplements, data should be included with nutrient intakes from foods to correctly determine total nutrient exposure.
Assuntos
Suplementos Nutricionais/estatística & dados numéricos , Micronutrientes/administração & dosagem , Fitoterapia/estatística & dados numéricos , Adolescente , Adulto , Fatores Etários , Idoso , Criança , Pré-Escolar , Estudos Transversais , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Inquéritos Nutricionais , Obesidade/tratamento farmacológico , Extratos Vegetais/uso terapêutico , Fatores Socioeconômicos , Inquéritos e Questionários , Estados Unidos , Adulto JovemRESUMO
OBJECTIVE: To describe dietary supplement use among US children. DESIGN: Analysis of nationally representative data from the 1999-2002 National Health and Nutrition Examination Survey (NHANES). SETTING: Home interviews and a mobile examination center. PARTICIPANTS: Children from birth through 18 years who participated in NHANES (N=10,136). MAIN EXPOSURE: Frequency of use of any dietary supplement product. OUTCOME MEASURE: Prevalence of use and intake of key nutrients from supplements among children. RESULTS: In 1999-2002, 31.8% of children used dietary supplements, with the lowest use reported among infants younger than 1 year (11.9%) and teenagers 14 to 18 years old (25.7%) and highest use among 4- to 8-year-old children (48.5%). Use was highest among non-Hispanic white (38.1%) and Mexican American (22.4%) participants, lowest among non-Hispanic black participants (18.8%), and was not found to differ by sex. The type of supplement most commonly used was multivitamins and multiminerals (18.3%). Ascorbic acid (28.6%), retinol (25.8%), vitamin D (25.6%), calcium (21.1%), and iron (19.3%) were the primary supplemental nutrients consumed. Supplement use was associated with families with higher incomes; a smoke-free environment; not being certified by the US Department of Agriculture Special Supplemental Nutrition Program for Women, Infants and Children in the last 12 months; lower child body mass index; and less daily recreational screen time (television, video games, computers, etc) (P<.005). The highest prevalence of supplement use (P<.005) was in children who were underweight or at risk for underweight (P<.005). CONCLUSIONS: More than 30% of children in the United States take dietary supplements regularly, most often multivitamins and multiminerals. Given such extensive use, nutrient intakes from dietary supplements must be included to obtain accurate estimates of overall nutrient intake in children.
Assuntos
Proteção da Criança/estatística & dados numéricos , Suplementos Nutricionais/estatística & dados numéricos , Inquéritos Nutricionais , Adolescente , Fatores Etários , Índice de Massa Corporal , Criança , Pré-Escolar , Estudos Transversais , Dieta , Suplementos Nutricionais/classificação , Feminino , Humanos , Lactente , Recém-Nascido , Entrevistas como Assunto , Masculino , Valor Nutritivo , Prevalência , Estados UnidosRESUMO
In May of 2013, porcine epidemic diarrhea virus (PEDV) was detected in swine for the first time in North America. It spread rapidly, in part due to contaminated livestock trailers. The objective of this study was to test the efficacy of an accelerated hydrogen peroxide disinfectant for inactivating PEDV in the presence of feces on metal surfaces, such as those found in livestock trailers. Three-week-old barrows were inoculated intragastrically with 5 mL of PEDV-negative feces for the negative control, 5 mL of untreated PEDV-positive feces for the positive control, and 5 mL or 10 mL of PEDV-positive feces that was subjected to treatment with a 1:16 or 1:32 concentrations of accelerated hydrogen peroxide disinfectant for a contact time of 30 min at 20°C. These pigs served as a bioassay to determine the infectivity of virus following treatment. Rectal swabs collected from the inoculated pigs on days 3 and 7 post-inoculation were tested by using PEDV-specific real-time reverse transcription polymerase chain reaction and the proportion of pigs in each group that became infected with PEDV was assessed. None of the pigs used for the bioassay in the 4 treatment groups and the negative control group became infected with PEDV, which was significantly different from the positive control group (P < 0.05) in which all pigs were infected. The results suggest that the application of the accelerated hydrogen peroxide under these conditions was sufficient to inactivate the virus in feces found on metal surfaces.
En mai 2013, pour la première fois en Amérique du Nord, le virus de la diarrhée épidémique porcine (VDEP) fut détecté chez le porc. Il se répandit rapidement, en partie à cause des remorques pour animaux contaminées. L'objectif de la présente étude était de tester l'efficacité d'un désinfectant à base de peroxyde d'hydrogène accéléré pour inactiver le VDEP en présence de fèces sur des surfaces métalliques, telles que celles retrouvées dans les remorques pour animaux. Des mâles castrés âgés de 3 semaines ont été inoculés par voie intra-gastrique avec 5 mL de fèces VDEP-négatives pour les témoins négatifs, 5 mL de fèces VDEP-positives non traitées pour les témoins positifs, et 5 mL ou 10 mL de fèces VDEP-positives soumises à un traitement au désinfectant à base de peroxyde d'hydrogène accéléré à une concentration de 1:16 ou 1:32 avec un temps de contact de 30 min à 20 °C. Les porcs ont servi de bioessai afin de déterminer l'infectivité du virus suite au traitement. Des écouvillons rectaux prélevés des porcs inoculés aux jours 3 et 7 post-inoculation ont été testés par réaction d'amplification en chaine en temps réel utilisant la transcriptase réverse et spécifique au VDEP, et la proportion de porcs devenus infectés par le VDEP dans chaque groupe fut déterminée. Aucun des porcs utilisés pour le bioessai dans les quatre groupes de traitement ainsi que dans le groupe témoin négatif ne devint infecté par le VDEP ce qui était significativement différent des animaux du groupe témoin positif (P < 0,05) qui devinrent tous positifs. Ces résultats suggèrent que l'application du peroxyde d'hydrogène accéléré dans les conditions testées était suffisante pour inactiver le virus présent dans les fèces sur les surfaces métalliques.(Traduit par Docteur Serge Messier).
Assuntos
Infecções por Coronavirus/veterinária , Desinfetantes/farmacologia , Peróxido de Hidrogênio/farmacologia , Vírus da Diarreia Epidêmica Suína/efeitos dos fármacos , Doenças dos Suínos/virologia , Animais , Bioensaio , Infecções por Coronavirus/prevenção & controle , Infecções por Coronavirus/virologia , Desinfetantes/química , Fezes/virologia , Peróxido de Hidrogênio/química , Metais , Suínos , Doenças dos Suínos/prevenção & controleRESUMO
There is considerable consumer and physician interest in vitamin D as a possible therapeutic agent for a range of clinical conditions and, despite mixed evidence, the interest does not appear to lessen. Some clinicians believe that consumption of vitamin D is inadequate and, in turn, advocate vitamin D supplementation to increase serum levels of the nutrient. However, evidence concerning the role of vitamin D in health and disease is conflicting, and primary care physicians have little time to sort through the data and may find it difficult to advise their patients. To better understand the challenges that primary care physicians face regarding vitamin D, and to help inform those who provide guidance for clinical decision-making, the Office of Dietary Supplements at the National Institutes of Health, with co-sponsorship from other federal health agencies, held a conference titled Vitamin D: Moving Toward Evidence-based Decision Making in Primary Care in December 2014. More than 20 invited presenters and panelists considered laboratory methods for measuring vitamin D status, discussed how clinical studies of vitamin D should be evaluated and used in developing recommendations, noted the role of values and preferences in clinical decision-making, debated the current science related to at-risk groups, and described emerging data about health risks of excessive intakes of vitamin D. Eight questions about vitamin D stem from the Conference presentations as well as other expert sources.
Assuntos
Atenção Primária à Saúde , Deficiência de Vitamina D/tratamento farmacológico , Vitamina D/uso terapêutico , Vitaminas/uso terapêutico , Tomada de Decisão Clínica , Suplementos Nutricionais/efeitos adversos , Medicina Baseada em Evidências , Humanos , National Institutes of Health (U.S.) , Estados Unidos , Vitamina D/efeitos adversos , Deficiência de Vitamina D/complicações , Deficiência de Vitamina D/diagnóstico , Deficiência de Vitamina D/prevenção & controle , Vitaminas/efeitos adversosRESUMO
BACKGROUND: Bedside ultrasound is increasingly commonly used by surgeons in their everyday practice. Little is known on the practical implications of bedside ultrasound, its efficacy and safety. OBJECTIVES: To carry out a review of the literature on bedside ultrasound as performed by surgeons. METHODS: Searching was carried out through Ovid Medline 1950 to current; the Ovid EMBASE 1980 to current; Cochrane Database of Systematic Reviews, PubMed and Google Scholar. Studies were eligible if they were any type of study relating to ultrasound scanning performed by surgeons or non-radiologists, using portable equipment and assessed as relevant by two reviewers. A narrative synthesis of the eligible studies was presented. RESULTS: There was moderately good evidence for the routine use of ultrasound by surgeons at the bedside for Gallbladder, Thyroid, Parathyroid, DVT scanning and trauma scanning. There was weaker evidence for aortic, hernia, breast, arterial and venous scanning. CONCLUSIONS: Evidence exists for the routine use of certain types of bedside ultrasound in surgical practice, especially in hepatobiliary and head and neck scanning. Further study is needed to determine its utility in vascular, hernia and breast ultrasound.
Assuntos
Sistemas Automatizados de Assistência Junto ao Leito , Procedimentos Cirúrgicos Operatórios/métodos , Ultrassonografia/métodos , Cirurgia Geral/métodos , Humanos , Médicos , Procedimentos Cirúrgicos Operatórios/efeitos adversos , Ultrassonografia/efeitos adversosRESUMO
BACKGROUND: Dietary supplements are used by more than half of adults, although to our knowledge, the reasons motivating use have not been previously examined in US adults using nationally representative data. The purpose of this analysis was to examine motivations for dietary supplement use, characterize the types of products used for the most commonly reported motivations, and to examine the role of physicians and health care practitioners in guiding choices about dietary supplements. METHODS: Data from adults (≥20 years; n = 11 956) were examined in the 2007-2010 National Health and Nutrition Examination Survey, a nationally representative, cross-sectional, population-based survey. RESULTS: The most commonly reported reasons for using supplements were to "improve" (45%) or "maintain" (33%) overall health. Women used calcium products for "bone health" (36%), whereas men were more likely to report supplement use for "heart health or to lower cholesterol" (18%). Older adults (≥60 years) were more likely than younger individuals to report motivations related to site-specific reasons like heart, bone and joint, and eye health. Only 23% of products were used based on recommendations of a health care provider. Multivitamin-mineral products were the most frequently reported type of supplement taken, followed by calcium and ω-3 or fish oil supplements. Supplement users are more likely to report very good or excellent health, have health insurance, use alcohol moderately, eschew cigarette smoking, and exercise more frequently than nonusers. CONCLUSIONS: Supplement users reported motivations related to overall health more commonly than for supplementing nutrients from food intakes. Use of supplements was related to more favorable health and lifestyle choices. Less than a quarter of supplements used by adults were recommended by a physician or health care provider.
Assuntos
Atitude Frente a Saúde , Suplementos Nutricionais , Micronutrientes , Motivação , Papel do Médico , Adulto , Fatores Etários , Índice de Massa Corporal , Interpretação Estatística de Dados , Suplementos Nutricionais/classificação , Suplementos Nutricionais/estatística & dados numéricos , Feminino , Comportamentos Relacionados com a Saúde , Nível de Saúde , Humanos , Estilo de Vida , Masculino , Micronutrientes/administração & dosagem , Micronutrientes/classificação , Pessoa de Meia-Idade , Inquéritos Nutricionais , Necessidades Nutricionais , Medicina Preventiva/métodos , Medicina Preventiva/estatística & dados numéricos , Fatores Sexuais , Fatores Socioeconômicos , Estados UnidosAssuntos
Suplementos Nutricionais , Oligoelementos/administração & dosagem , Vitaminas/administração & dosagem , Adulto , Idoso , Relação Dose-Resposta a Droga , Feminino , Inocuidade dos Alimentos , Humanos , Masculino , Pessoa de Meia-Idade , Recomendações Nutricionais , Oligoelementos/análise , Vitaminas/análise , Adulto JovemRESUMO
Acetabular component extraction following intra-pelvic migration of a total hip replacement can be hazardous to pelvic tissues, vessels and organs. Acetabular component removal is usually performed using an abdominal retroperitoneal approach. We describe a closed reduction of the acetabular component using a traction/manipulation technique. This manoeuvre can be used in cases of intra-pelvic acetabular component migration where the surface contour of the acetabular component is uncomplicated and an interposition membrane separates the implant from adjacent intra-pelvic structures.